Anebulo Pharmaceuticals (ANEB) Stock Chart & Stock Price History → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free ANEB Stock Alerts $2.05 -0.05 (-2.38%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Anebulo Pharmaceuticals Stock Price Performance5 Day Performance-3.30%1 Month Performance-30.74%3 Month Performance-25.45%6 Month Performance-13.50%Year-To-Date Performance-15.29%1 Year Performance-18.00% Receive ANEB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThis military-backed stock “owns” AI marketThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. ANEB Stock Chart for Saturday, June, 1, 2024 ANEB Chart by TradingView Anebulo Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.10$2.05-2.38%$2.05$2.051,130 shs$54.46 million05/30/2024$2.05$2.10+2.44%$2.10$2.10608 shs$54.45 million05/29/2024$2.08$2.05-1.44%$2.15$2.052,611 shs$53.16 million05/28/2024$2.12$2.08-1.89%$2.18$2.07630 shs$53.93 million05/27/2024$2.12$2.12+0.24%$2.23$2.055,000 shs$54.97 million05/24/2024$2.11$2.12+0.24%$2.23$2.055,087 shs$54.84 million Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.10$2.11+0.48%$2.22$2.052,088 shs$54.71 million05/22/2024$2.11$2.10-0.47%$2.17$2.101,152 shs$54.45 million05/21/2024$2.15$2.11-1.86%$2.21$2.11767 shs$54.72 million05/20/2024$2.30$2.15-6.52%$2.26$2.151,960 shs$55.75 million05/17/2024$2.21$2.30+4.07%$2.30$2.057,256 shs$58.95 million05/16/2024$2.35$2.21-5.96%$2.45$2.2011,708 shs$56.64 million05/15/2024$2.28$2.35+3.07%$2.82$2.2514,979 shs$60.23 million05/14/2024$2.41$2.28-5.39%$2.51$2.2014,760 shs$58.44 million05/13/2024$3.01$2.41-19.93%$3.10$2.4030,613 shs$61.77 million05/10/2024$3.00$3.01+0.33%$3.13$2.837,397 shs$77.15 million05/09/2024$3.01$3.00-0.33%$3.04$3.002,193 shs$76.89 million05/08/2024$3.04$3.01-0.99%$3.01$2.83132 shs$77.15 million05/07/2024$2.95$3.04+3.05%$3.18$3.041,541 shs$77.92 million05/06/2024$2.95$2.95$3.17$2.791,663 shs$75.62 million05/03/2024$3.12$2.95-5.45%$3.13$2.913,650 shs$75.61 million05/02/2024$2.96$3.12+5.41%$3.20$3.098,476 shs$79.97 million05/01/2024$2.90$2.96+2.07%$3.07$2.943,863 shs$75.87 million04/30/2024$2.80$2.90+3.57%$2.90$2.8118,500 shs$74.33 million04/29/2024$2.70$2.80+3.57%$2.80$2.671,600 shs$71.76 million04/26/2024$2.79$2.70-3.25%$2.70$2.70387 shs$69.29 million04/25/2024$2.79$2.79+0.16%$2.79$2.761,785 shs$71.62 million04/24/2024$2.71$2.79+2.95%$2.79$2.618,275 shs$71.51 million04/23/2024$2.65$2.71+2.26%$2.71$2.70794 shs$69.46 million04/22/2024$2.78$2.65-4.68%$2.77$2.651,495 shs$67.93 million04/19/2024$2.75$2.78+1.09%$2.79$2.75711 shs$71.25 million04/18/2024$3.00$2.75-8.33%$3.30$2.754,903 shs$70.48 million04/17/2024$2.96$3.00+1.35%$3.00$2.78992 shs$76.89 million04/16/2024$2.96$2.96$2.96$2.96222 shs$75.87 million04/15/2024$2.91$2.96+1.89%$3.08$2.961,717 shs$75.87 million04/12/2024$2.89$2.96+2.42%$3.07$2.8010,120 shs$75.87 million04/11/2024$2.60$2.89+11.15%$2.89$2.612,079 shs$74.07 million04/10/2024$2.71$2.60-4.06%$2.60$2.602,550 shs$66.64 million04/09/2024$2.78$2.71-2.52%$2.98$2.7127,625 shs$69.46 million04/08/2024$2.78$2.78-0.01%$3.10$2.781,688 shs$71.26 millionOn June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are.04/05/2024$2.91$2.78-4.47%$3.09$2.7619,089 shs$71.25 million04/04/2024$2.88$2.91+1.04%$2.91$2.84222 shs$74.58 million04/03/2024$2.83$2.88+1.77%$3.00$2.805,151 shs$73.81 million04/02/2024$3.04$2.83-6.91%$2.97$2.724,238 shs$72.53 million04/01/2024$2.87$3.04+5.92%$3.14$2.877,914 shs$77.92 million03/29/2024$2.87$2.87$3.09$2.873,912 shs$73.56 million03/28/2024$2.78$2.87+3.24%$3.09$2.873,912 shs$73.56 million03/27/2024$2.60$2.78+6.92%$3.05$2.6111,234 shs$71.25 million03/26/2024$2.50$2.60+4.10%$2.71$2.602,755 shs$66.64 million03/25/2024$2.50$2.50-0.10%$2.50$2.455,029 shs$64.01 million03/22/2024$2.40$2.50+4.17%$2.50$2.401,188 shs$64.08 million03/21/2024$2.40$2.40$2.40$2.40961 shs$61.51 million03/20/2024$2.40$2.40$2.52$2.402,761 shs$61.51 million03/19/2024$2.40$2.40$2.50$2.405,784 shs$61.52 million03/18/2024$2.54$2.40-5.51%$2.51$2.403,837 shs$61.51 million03/15/2024$2.42$2.54+4.96%$2.68$2.4216,651 shs$65.10 million03/14/2024$2.42$2.42$2.42$2.42770 shs$62.03 million03/13/2024$2.45$2.42-1.22%$2.56$2.423,661 shs$62.03 million03/12/2024$2.77$2.45-11.55%$2.76$2.4514,111 shs$62.79 million03/11/2024$2.95$2.77-6.10%$2.77$2.77589 shs$71.00 million03/08/2024$2.91$2.95+1.37%$2.95$2.807,442 shs$75.61 million03/07/2024$2.74$2.91+6.20%$3.10$2.705,313 shs$74.58 million03/06/2024$2.87$2.74-4.53%$2.74$2.74415 shs$70.23 million03/05/2024$2.87$2.87$3.21$2.7912,802 shs$73.56 million03/04/2024$2.75$2.87+4.36%$3.17$2.756,411 shs$73.56 million03/01/2024$2.72$2.75+1.10%$2.85$2.752,447 shs$70.48 million02/29/2024$2.82$2.72-3.55%$3.14$2.722,277 shs$69.72 million Related Companies: Sol-Gel Technologies Stock Price Chart Tonix Pharmaceuticals Stock Price Chart OptiNose Stock Price Chart Eliem Therapeutics Stock Price Chart G1 Therapeutics Stock Price Chart Ovid Therapeutics Stock Price Chart Werewolf Therapeutics Stock Price Chart Conduit Pharmaceuticals Stock Price Chart Renovaro Stock Price Chart Generation Bio Stock Price Chart Receive ANEB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ANEB) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.